Ars Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.69

+0.41 (+3.99%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +516.6% upside

Low Target $44.11

Average Target $65.91

High Target $67.85

Current Price $10.69

Current
$10.69

Target
$65.91

$44.11 $65.91 avg $67.85

Scenario Analysis

Bear Case

$44.11

312.6%

Low target

Base Case

$65.91

+516.6%

Avg target

Bull Case

$67.85

+534.7%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$18.90

-43.4% from high

52-Week Low

$6.66

+60.5% from low

Target vs 52W High

$65.91

+248.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%